Lyophilized Powder Peptide Egrifta Tesamorelin for Bodybuilding
Tesamorelin powder is a synthetic hormone-releasing factor that stimulates the pituitary gland in the brain to secrete hormone; this indirect approach appears to maintain more stable, natural levels, like CJC-1295 DAC,Clinical trials have shown that tesamorelin significantly reduces abdominal fat with fewer side effects than human hormone itself, although abdominal fat may return after the Tesamorlein is discontinued (depending upon the individual). Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals as well as similarly reducing abdominal fat in NON-HIV-Infected individuals.
CAS No.: 106612-94-6
Purity (HPLC): 99.0%
Appearance: White powder
Molecular Formula: C151H228N40O47
Molecular Weight: 3355.67
Single Impurity (HPLC): 0.5%max
Amino Acid Composition: ± 10% of theoretical
Peptide Content(N%): ≥ 80.0%
Water Content(Karl Fischer): ≤ 8.0%
Acetate Content(HPIC): ≤ 10.0%
Specific Rotation (20/D): -55.0~-65.0° (c=1 1%HAc)
Mass Balance: 95.0~105.0%
Tesamorelin is an analogue of GHRH (releasing hormone, a naturally-occurring peptide released from the hypothalamus) that was recently approved by the FDA for treatment (reduction) of HIV-induced lipodystrophy-related visceral fat and is now marketed under the trade name Egrifta. Like GHRH, tesamorelin exerts its effects through inducing GH release from the pituitary.